These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8163763)
1. In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function. Lachmann B; Eijking EP; So KL; Gommers D Intensive Care Med; 1994; 20(1):6-11. PubMed ID: 8163763 [TBL] [Abstract][Full Text] [Related]
2. Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome. Häfner D; Germann PG; Hauschke D Br J Pharmacol; 1998 Jul; 124(6):1083-90. PubMed ID: 9720777 [TBL] [Abstract][Full Text] [Related]
3. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS). Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456 [TBL] [Abstract][Full Text] [Related]
4. Exogenous surfactant therapy increases static lung compliance, and cannot be assessed by measurements of dynamic compliance alone. Gommers D; Vilstrup C; Bos JA; Larsson A; Werner O; Hannappel E; Lachmann B Crit Care Med; 1993 Apr; 21(4):567-74. PubMed ID: 8472578 [TBL] [Abstract][Full Text] [Related]
5. The effects of multiple small doses of exogenous surfactant on experimental respiratory failure induced by lung lavage in rats. Alvarez FJ; Alfonso LF; Gastiasoro E; Lopez-Heredia J; Arnaiz A; Valls-i-Soler A Acta Anaesthesiol Scand; 1995 Oct; 39(7):970-4. PubMed ID: 8848901 [TBL] [Abstract][Full Text] [Related]
6. Bronchoalveolar lavage with a diluted surfactant suspension prior to surfactant instillation improves the effectiveness of surfactant therapy in experimental acute respiratory distress syndrome (ARDS). Gommers D; Eijking EP; So KL; van't Veen A; Lachmann B Intensive Care Med; 1998 May; 24(5):494-500. PubMed ID: 9660267 [TBL] [Abstract][Full Text] [Related]
7. Comparison of exogenous surfactant therapy, mechanical ventilation with high end-expiratory pressure and partial liquid ventilation in a model of acute lung injury. Hartog A; Vazquez de Anda GF; Gommers D; Kaisers U; Verbrugge SJ; Schnabel R; Lachmann B Br J Anaesth; 1999 Jan; 82(1):81-6. PubMed ID: 10325841 [TBL] [Abstract][Full Text] [Related]
8. Improvement of lung mechanics by exogenous surfactant: effect of prior application of high positive end-expiratory pressure. Hartog A; Gommers D; Haitsma JJ; Lachmann B Br J Anaesth; 2000 Nov; 85(5):752-6. PubMed ID: 11094593 [TBL] [Abstract][Full Text] [Related]
9. Exogenous pulmonary surfactant as a drug delivering agent: influence of antibiotics on surfactant activity. van 't Veen A; Gommers D; Mouton JW; Kluytmans JA; Krijt EJ; Lachmann B Br J Pharmacol; 1996 Jun; 118(3):593-8. PubMed ID: 8762082 [TBL] [Abstract][Full Text] [Related]
10. Surfactant treatment of respiratory failure induced by hydrochloric acid aspiration in rats. Eijking EP; Gommers D; So KL; Vergeer M; Lachmann B Anesthesiology; 1993 Jun; 78(6):1145-51. PubMed ID: 8512108 [TBL] [Abstract][Full Text] [Related]
11. Aerosolized surfactant in lung-lavaged adult rats: factors influencing the therapeutic response. Bahlmann H; Sun B; Nilsson G; Curstedt T; Robertson B Acta Anaesthesiol Scand; 2000 May; 44(5):612-22. PubMed ID: 10786751 [TBL] [Abstract][Full Text] [Related]
12. Surfactant pretreatment decreases long-term damage after ischemia-reperfusion injury of the lung. van der Kaaij NP; Kluin J; Haitsma JJ; den Bakker MA; Lambrecht BN; Lachmann B; de Bruin RW; Bogers AJ Eur J Cardiothorac Surg; 2009 Feb; 35(2):304-12; discussion 312. PubMed ID: 19109031 [TBL] [Abstract][Full Text] [Related]
13. The fate of exogenous surfactant in neonates with respiratory distress syndrome. Hallman M; Merritt TA; Bry K Clin Pharmacokinet; 1994 Mar; 26(3):215-32. PubMed ID: 8194284 [TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-inhibition enhances the effects of rSP-C surfactant therapy in a rat lavage model of acute respiratory distress syndrome (ARDS). Häfner D; Ibrahim M; Wollin L; Germann PG Exp Toxicol Pathol; 2003 Jul; 55(1):59-68. PubMed ID: 12940630 [TBL] [Abstract][Full Text] [Related]
15. Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage. Berggren P; Lachmann B; Curstedt T; Grossmann G; Robertson B Acta Anaesthesiol Scand; 1986 May; 30(4):321-8. PubMed ID: 3090844 [TBL] [Abstract][Full Text] [Related]
16. Improved oxygenation by nitric oxide is enhanced by prior lung reaeration with surfactant, rather than positive end-expiratory pressure, in lung-lavaged rabbits. Gommers D; Hartog A; van 't Veen A; Lachmann B Crit Care Med; 1997 Nov; 25(11):1868-73. PubMed ID: 9366772 [TBL] [Abstract][Full Text] [Related]
17. Lodixanol inhibits exogenous surfactant therapy in rats with acute respiratory distress syndrome. Kesecioglu J; Schultz MJ; Haitsma JJ; den Heeten GJ; Lachmann B Eur Respir J; 2002 May; 19(5):820-6. PubMed ID: 12030719 [TBL] [Abstract][Full Text] [Related]
18. Surfactant replacement therapy in animal models of respiratory failure due to viral infection. van 't Veen A; So KL; Lachmann B Adv Exp Med Biol; 1994; 345():83-94. PubMed ID: 8079794 [No Abstract] [Full Text] [Related]
19. Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates. Gortner L; Maroske W; Reiss I; Weller E Arzneimittelforschung; 2006; 56(1):25-32. PubMed ID: 16478002 [TBL] [Abstract][Full Text] [Related]
20. Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury. Vangerow B; Häfner D; Rueckoldt H; Marx G; Ott N; Leuwer M; Frerking I; Germann PG Intensive Care Med; 2001 Sep; 27(9):1526-31. PubMed ID: 11685347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]